Calidi Biotherapeutics, Inc.
CLDWW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCLDI
Q4 2023 vs. Q3 2023
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 22 | 18 | −4 |
| Shares | 6.18M | 5.63M | −544.1K (−8.8%) |
| Value | $1.64M | $384.0K | −$1.26M (−76.6%) |
New holders (0)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
None.
Sold out (4)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Periscope Capital Inc. | 200,000 | $44.0K |
| Ionic Capital Management LLC | 75,172 | $16.5K |
| UBS Group AG | 80 | $18 |
| Bank of America Corp | 50 | $11 |